An interdisciplinary collaboration used a cutting-edge form of RNA tagging to map the gene expression that occurs during follicle maturation and ovulation in mice, an approach that could lead to therapeutic treatments for infertility.
Ekta Khurana, associate professor of physiology and biophysics at Weill Cornell Medicine, has received a three-year, $1.2 million grant from the United States Department of Defense to investigate how prostate cancer cells evolve to become resistant to hormone-blocking therapy.
New research has shown that ultrasmall Cornell Prime Dots, or C’Dots, which are among the nanocarriers for therapeutics once thought to be viable only by injection, have the potential to be administered orally.
The Cornell High Energy Synchrotron Source (CHESS) is set to host the Pan American Light Sources for Agriculture conference (PALSA) July 11-14. Registration is still open.
Our 11th episode features Stephanie Wisner ’16, co-founder of Centivax, a therapeutics company that’s creating universal vaccines to reduce and eradicate the remaining complex pathogens of the 21st century.
New research used engineered mice to compare SARS-COV-2 omicron subvariants, and found one of them, BA.5, was more virulent likely due to its ability to rapidly replicate early during infection.
Deer hunters were more likely to be swayed by social media messages about the potential risks of chronic wasting disease if they came from a source they believed aligned with their own views and values.
Shawon Debnath, a research associate in pathology and laboratory medicine at Weill Cornell Medicine, has been honored with a 2023 Tri-Institutional Breakout Award for Junior Investigators.